Physiomics Share Discussion Threads

[davevt] 10/9/2018 09:30

Myamay, so what? Pyc didn't help design this drug, they only work out what dose the client should use for trials and how often they give it to the patients.

The drugs success or not is not related to pycs service.

It also depends if they actually need pycs service too. I think people seem to forget that drug companies already work out their own dosage requirements, maybe in a slower or long winded way (maybe in a better way hence why not using pyc) . All pyc offers is their own dose prediction service. That's it.

[myamay16] 09/9/2018 23:34

My reasoning for the positive change with PYC is due to the outcome of the contract taken out on 9th of Feb this year.
If the research I carried out is correct, the biopharma involved, has had its drug combo validated with positive results and approved, all within the last 6 months.
Depends now if PYC are able to disclose this information.

[pwhite73] 09/9/2018 07:32

AIM stocks are no different from you running your own private business.

a) You need to demonstrate to your employees, trade partners, creditors and the wider business community that your business is doing well and growing. But:-

b) In order to lessen your tax burden you need to demonstrate to HMRC that your business is trading poorly and losing money.

PYC meets both challenges. The actual trading side of the business is close to zero so it is able to report losses to HMRC year after year. However the reality is that the business is thriving and highly lucrative but on mug PI money. Mug PI money is what has afforded the directors here executive lifestyles for 15 years.

[spacedust] 07/9/2018 13:02

Only a director purchase can restore cunning jims trust

[davevt] 07/9/2018 12:12

It doesn't matter though if they are ahead of market 'expectations' though.

I don't know about you, but when I'm in business for ten years, I would expect to turn a profit.

They are ahead of market expectations and still making a loss. Translate that to 'we've had a busy year this year and still not making any money. You'd be better off saying 'were still making a loss, but have had hardly any customers so there is room for improvement.

[howdlep] 07/9/2018 11:00

yep time to fill that gap. Then we can have the big news....

[cinquepercento] 07/9/2018 10:46

Rightly or wrongly,I see the start of a spike now to about 6 or so followed by a fall back to resume its descent.

[howdlep] 07/9/2018 10:25

but when a company gets close to profitabilty and then turns profitable, that growth phase is very rapid indeed.

We already know that forthcoming results are ahead of market expectations, so it is all about the forward looking statement and new contract awards.

The window of opportunity is narrowing. We are close to a real breakout. With that, comes greater trading volumes.

[davevt] 07/9/2018 10:16

Stig is talking complete waffle again comparing pyc to companies that are nothing like them.

Remember, old tech, limited amount of potential customers, tens years running at a loss,

[the stigologist] 07/9/2018 10:00

10-20x valuation on current £0.75m run rate revenue suggests we should be trading at 10-20p anyway right now

[spacedust] 07/9/2018 09:54

Is there light at the end of this long deep narrow dark tunnel???

[the stigologist] 07/9/2018 09:48

50p would be a £35m market cap

working backwards given 20x revenue multiples in this Industry (i.e. Nasdaq listed Simulations Plus (SLP)) would require revenue of c. £1.75m

Given £0.75m run rate from Merck + other bios + Government grants it only needs either 2 more Merck size contract or 1 mega contract to get towards that 50p+ share price

[the stigologist] 07/9/2018 09:45

a moonshoot to 10p+ 16p ? looks nailed on here...soon

what would a Glaxo deal do ?

50p+ ?

[the stigologist] 07/9/2018 09:18

Breaking above 4.50

very significant

multiple news items pending

[herb clark] 07/9/2018 09:14

My buy is showing as a sell.

[spacedust] 07/9/2018 08:33

Any sort of blue finish today will make the chart look poised for a sharp move north.

[howdlep] 07/9/2018 08:03

the key thing is the direction of price movement. However, people do constantly misinterpret delayed trades, as NMS is used to provide liquidity (control trades) and ensure an orderly market. Far from me to suggest MM's use it for other reasons.

However, this all detracts from yesterday's very positive day. That £20k delayed buy trade really got things moving. Let's see the price direction today. I remain very bullish, as we look to take out some clear chart technicals over the coming sessions.

[turbotrader2] 07/9/2018 07:55

Expect another move here today

[spacedust] 07/9/2018 07:27

Ok I get your point.

I thought you will say the bit about for every buyer seller story. Which I disagree with.

If we have constant buys for th next year then price will go up simples.

[davevt] 07/9/2018 00:30

No you're missing my point. Think of the mid point as a flag on a rope constantly being pulled back and forth. The price you see on a site isn't live, it's lagged and delayed. The mid point price is constantly moving. So when you see a buy or sell reported, it's delayed, and it can simply be at the time of reporting the mid point as moved, the buy price is now below the mid point and 'reported as a sell'. It makes no difference what so ever. If the share price was 4 for instance, and then the bid was put up to 4.5 and an ask of 5, and all the trades that day were sells, the share price would go up would it not?

Once again, it matters not if it's a buy or a sell, it's a TRADE, at a price.

[spacedust] 06/9/2018 22:01

....have happened

[spacedust] 06/9/2018 22:01

Dave it makes a huge difference. If a company has 100 shares in issue and 10 people want to buy all 100 shares what do you think will have